Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

The 10 Best Stocks to Buy for a Whole New Year of Returns

By Thomas Niel, InvestorPlace Contributor

As we ring in 2022, consider the following ten names, a mix of growth and value plays, stocks to buy. Each one has high potential to deliver stunning returns. Academy Sports and Outdoors (NASDAQ:ASO)  CommVault Systems (NASDAQ:CVLT) EVgo (NASDAQ:EVGO) Gores Guggenheim (NASDAQ:GGPI) Kohl’s (NYSE:KSS) Pinterest (NYSE:PINS) Sundial Growers (NASDAQ:SNDL) AT&T (NYSE:T) Tenneco (NYSE:TEN) ViacomCBS (NASDAQ:VIAC)

Don’t Bet on a Turnaround in ContextLogic Stock in 2022

By Thomas Niel, InvestorPlace Contributor

Betting on WISH stock as a turnaround play or takeover target is a huge gamble. There are plenty of better moonshots to roll the dice on. 

Despite Musk’s Recent Touting, Don’t Count on a Dogecoin Rebound

By Thomas Niel, InvestorPlace Contributor

Even if you're confident crypto is making a comeback next year, Dogecoin still isn't the best way to play it. Stick to more promising altcoins, or perhaps Ethereum itself, to make that wager.

Don’t Read Too Much into Novavax’s Recent Pullback

By Thomas Niel, InvestorPlace Contributor

Still a vaccine play with high potential, consider NVAX stock a buy at today's prices.

Meta Platforms Stock Still Is the Best Investment in the Metaverse Out There

By Thomas Niel, InvestorPlace Contributor

If placing bets on the metaverse, go with FB stock. It offers greater exposure to the trend than its peers, as well as a lower valuation.

Load More